JP2016528202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016528202A5 JP2016528202A5 JP2016524930A JP2016524930A JP2016528202A5 JP 2016528202 A5 JP2016528202 A5 JP 2016528202A5 JP 2016524930 A JP2016524930 A JP 2016524930A JP 2016524930 A JP2016524930 A JP 2016524930A JP 2016528202 A5 JP2016528202 A5 JP 2016528202A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- administered
- vegf antagonist
- disorder
- child
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845064P | 2013-07-11 | 2013-07-11 | |
| US61/845,064 | 2013-07-11 | ||
| PCT/IB2014/062978 WO2015004616A1 (en) | 2013-07-11 | 2014-07-09 | Use of a vegf antagonist in treating chorioretinal neovascular and permeability disorders in paediatric patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016528202A JP2016528202A (ja) | 2016-09-15 |
| JP2016528202A5 true JP2016528202A5 (https=) | 2017-08-10 |
Family
ID=51211282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016524930A Pending JP2016528202A (ja) | 2013-07-11 | 2014-07-09 | 小児患者の脈絡網膜血管新生障害および透過性障害の治療におけるｖｅｇｆアンタゴニストの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160168240A1 (https=) |
| EP (1) | EP3019526A1 (https=) |
| JP (1) | JP2016528202A (https=) |
| KR (1) | KR20160029794A (https=) |
| CN (1) | CN105377891A (https=) |
| AU (2) | AU2014288837A1 (https=) |
| BR (1) | BR112016000177A2 (https=) |
| CA (1) | CA2917807A1 (https=) |
| MX (1) | MX2016000384A (https=) |
| RU (1) | RU2676274C2 (https=) |
| WO (1) | WO2015004616A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2494108C2 (ru) | 2006-04-07 | 2013-09-27 | Аерпио Терапетикс, Инк. | Антитела, которые связывают человеческий белок бета-тирозин фосфатазу (нртрвета), и их использование |
| US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| ES2726946T3 (es) | 2009-07-06 | 2019-10-10 | Aerpio Therapeutics Inc | Derivados de benzosulfonamida, composiciones de los mismos y su uso en la prevención de la metástasis de las células cancerosas |
| WO2013056240A1 (en) | 2011-10-13 | 2013-04-18 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome and cancer |
| US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
| EP3116503A4 (en) | 2014-03-14 | 2017-08-23 | Aerpio Therapeutics, Inc. | Hptp-beta inhibitors |
| CN106456757A (zh) * | 2014-05-12 | 2017-02-22 | 福尔密孔股份公司 | 含有vegf拮抗剂的预填充塑料注射器 |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| ES2894802T3 (es) | 2015-09-23 | 2022-02-15 | Aerpio Pharmaceuticals Inc | Activadores de Tie-2 para su uso en el tratamiento de la presión intraocular |
| CN108290004A (zh) * | 2015-11-18 | 2018-07-17 | 福尔密孔股份公司 | 含有vegf拮抗剂的预填充塑料注射器 |
| WO2017084616A1 (en) * | 2015-11-19 | 2017-05-26 | Zhuhai Tairuishang Biopharm Ltd. | Methods and compositions for binding vegf |
| KR20250057128A (ko) | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| EP3454903A4 (en) * | 2016-05-13 | 2020-08-19 | Askgene Pharma, Inc. | NEW DOUBLE ANTAGONISTS OF ANGIOPOIETIN 2, VEGF |
| BR112019001206A2 (pt) | 2016-07-20 | 2019-06-25 | Aerpio Therapeutics Inc | anticorpos monoclonais humanizados que visam ve-ptp (hptp-ss) |
| US20190388522A1 (en) * | 2017-01-25 | 2019-12-26 | Iconic Therapeutics, Inc. | Methods for treating disorders associated with angiogenesis and neovascularization |
| BR112019023061A2 (pt) * | 2017-05-01 | 2020-06-09 | Ojai Retinal Tech Llc | processo para prevenir ou tratar miopia |
| SG11202004560TA (en) * | 2017-11-16 | 2020-06-29 | Iveric Bio Inc | A method for treating or preventing idiopathic polypoidal choroidal vasculopathy (ipcv) |
| EP3758737A4 (en) | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| EP3962482A4 (en) | 2019-04-29 | 2023-01-11 | EyePoint Pharmaceuticals, Inc. | TIE 2 ACTIVATORS FACING THE SCHLEMM CHANNEL |
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| KR20220118419A (ko) * | 2019-12-19 | 2022-08-25 | 액티브 바이오테크 에이비 | 과도한 혈관신생과 관련된 안구 질병의 치료를 위한 화합물 |
| RU2762991C1 (ru) * | 2021-09-06 | 2021-12-24 | федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ лечения макулярного отека вследствие окклюзии ветви центральной вены сетчатки в сочетании с ретинальной артериолярной макроаневризмой |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| TW202525324A (zh) * | 2023-08-17 | 2025-07-01 | 大陸商信達生物製藥（蘇州）有限公司 | 治療年齡相關性黃斑變性和糖尿病性黃斑水腫的方法 |
| CN118085112B (zh) * | 2024-04-29 | 2024-08-09 | 上海鼎新基因科技有限公司 | 抗多个vegf家族蛋白的融合蛋白及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1404297B1 (en) | 2001-06-12 | 2011-04-27 | The Johns Hopkins University School Of Medicine | Reservoir device for intraocular drug delivery |
| WO2005110374A1 (en) | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| EP1767546B1 (en) | 2004-06-08 | 2012-03-07 | Chengdu Kanghong Biotechnologies Co., Ltd. | Angiogenesis-inhibiting chimeric protein and the use |
| US20070072933A1 (en) * | 2005-09-26 | 2007-03-29 | Peyman Gholam A | Delivery of an ocular agent |
| US8039010B2 (en) | 2006-11-03 | 2011-10-18 | Allergan, Inc. | Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| EP2247289A4 (en) * | 2008-02-21 | 2011-05-04 | Ista Pharmaceuticals | OPHTHALMIC NSAIDS AS ADJUVANTIES |
| WO2010045506A2 (en) * | 2008-10-16 | 2010-04-22 | Kathleen Cogan Farinas | Sustained drug delivery system |
| BRPI0921469B1 (pt) | 2008-11-03 | 2022-01-18 | Molecular Partners Ag | Proteínas de ligação que inibem a interação com o receptor de vegf-a, composição farmacêutica |
| MX337922B (es) * | 2008-12-16 | 2016-03-28 | Valeant Pharmaceuticals Int | Combinacion de terapia fotodinamica y agentes anti-vegf en el tratamiento de neovasculatura coroidal indeseable. |
| AU2010208046B2 (en) | 2009-01-29 | 2014-10-02 | Forsight Vision4, Inc. | Posterior segment drug delivery |
| EP3028707A1 (en) * | 2009-05-01 | 2016-06-08 | Ophthotech Corporation | Methods for treating or preventing ophthalmological diseases |
| AR081361A1 (es) | 2010-04-30 | 2012-08-29 | Molecular Partners Ag | Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a |
| RU2469734C2 (ru) * | 2010-09-02 | 2012-12-20 | Григорий Владимирович Пантелеев | Лечебное средство для лечения расстройств аккомодаций "stiak" |
-
2014
- 2014-07-09 EP EP14741406.4A patent/EP3019526A1/en not_active Withdrawn
- 2014-07-09 US US14/903,749 patent/US20160168240A1/en not_active Abandoned
- 2014-07-09 BR BR112016000177A patent/BR112016000177A2/pt not_active IP Right Cessation
- 2014-07-09 CN CN201480039606.4A patent/CN105377891A/zh active Pending
- 2014-07-09 MX MX2016000384A patent/MX2016000384A/es unknown
- 2014-07-09 WO PCT/IB2014/062978 patent/WO2015004616A1/en not_active Ceased
- 2014-07-09 CA CA2917807A patent/CA2917807A1/en not_active Abandoned
- 2014-07-09 KR KR1020167000239A patent/KR20160029794A/ko not_active Withdrawn
- 2014-07-09 AU AU2014288837A patent/AU2014288837A1/en not_active Abandoned
- 2014-07-09 JP JP2016524930A patent/JP2016528202A/ja active Pending
- 2014-07-09 RU RU2016104397A patent/RU2676274C2/ru not_active IP Right Cessation
-
2017
- 2017-06-09 AU AU2017203923A patent/AU2017203923B2/en not_active Ceased
-
2018
- 2018-02-27 US US15/906,421 patent/US20180194835A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016528202A5 (https=) | ||
| RU2016104397A (ru) | Применение антагониста vegf при лечении хориоретинальных неоваскулярных нарушений и нарушений проницаемости у педиатрических пациентов | |
| JP2016530280A5 (https=) | ||
| JP2015528454A5 (https=) | ||
| MX2017012506A (es) | Composicion farmaceutica para la prevencion y tratamiento de enfermedades del ojo que contiene, como ingrediente activo, una proteina de fusion en la cual el peptido que penetra el tejido y la preparacion del factor de crecimiento endotelial antivascular se fusionan. | |
| HRP20211453T1 (hr) | Liječenje amd uporabom aav sflt-1 | |
| JP2016523956A5 (https=) | ||
| JP2016065094A5 (https=) | ||
| JP2019510078A5 (https=) | ||
| MX349901B (es) | Uso de un antagonista de factor de crecimiento endotelial vascular para tratar transtornos oculares angiogenicos. | |
| RU2017119647A (ru) | Способ лечения болезней глаз | |
| JP2019504882A5 (https=) | ||
| JP2015525798A5 (https=) | ||
| RU2015117536A (ru) | Vegf-нейтрализирующие пролекарства для лечения офтальмологических заболеваний | |
| KR102373289B1 (ko) | 지속성 부종을 갖는 삼출성 노인성 황반변성을 치료하기 위한 시롤리무스의 용도 | |
| JP2012525415A5 (https=) | ||
| RU2017120361A (ru) | Антитела к pdgf-b и способы их применения | |
| JP2017503014A5 (https=) | ||
| JP2016516016A5 (https=) | ||
| JP2017533201A5 (https=) | ||
| JP2016027060A5 (https=) | ||
| JP2018521643A5 (https=) | ||
| HRP20191945T1 (hr) | Poboljšana il-6-protutijela | |
| JP2017534645A5 (https=) | ||
| JP2017512194A5 (https=) |